Cabıoğlu, N. Et Al. 2025. Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study. Clinical Breast Cancer .

Cabıoğlu, N., Karanlık, H., Özmen, V., Tükenmez, M., İğci, A., Aytin, Y. E., ... Köksal, H.(2025). Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study. Clinical Breast Cancer .

Cabıoğlu, Neslihan Et Al. "Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study," Clinical Breast Cancer , 2025

Cabıoğlu, Neslihan Et Al. "Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study." Clinical Breast Cancer , 2025

Cabıoğlu, N. Et Al. (2025) . "Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study." Clinical Breast Cancer .

@article{article, author={Neslihan Cabıoğlu Et Al. }, title={Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study}, journal={Clinical Breast Cancer}, year=2025}